drug

TT-01488

Phase 1updated 3mo ago

by TransThera Sciences (Nanjing) Inc

Phase 1

community read0 votes

indications

DLBCL

all catalysts(0)

nothing on the calendar yet

Trials studying TT-01488

phase1A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignanciesrecruitingn=37

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

TT-01488

Phase 1updated 3mo ago

by TransThera Sciences (Nanjing) Inc

Phase 1

community read0 votes

indications

DLBCL

all catalysts(0)

nothing on the calendar yet

Trials studying TT-01488

phase1A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignanciesrecruitingn=37

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

TT-01488

indications

all catalysts(0)

Trials studying TT-01488

News(0)

Report a data issue

comments(0)

TT-01488

indications

all catalysts(0)

Trials studying TT-01488

News(0)

Report a data issue

comments(0)